Zika Virus

The National Institutes of Health is embarking on a phase II trial of a DNA-based Zika vaccine, with the goal of enrolling almost 2,500 participants at sites, including one in Brazil run by GW faculty, spread across countries where the virus has infected people.

Roberta DeBiasi, M.D., professor of pediatrics and microbiology, immunology, and tropical medicine, discussed a recent report about Zika-infected women in the U.S.

The GW School of Medicine and Health Sciences’ International Medicine Programs and Department of Microbiology, Immunology, and Tropical Medicine are co-sponsoring a two-day scientific research summit with the Instituto Butantan and Universidade de São Paulo focused on Zika virus. The summit takes…

Tiana Garrett, Ph.D., M.P.H., discussed Zika virus updates from an epidemiological perspective in a Sept. 12 lecture.

GW physicians discuss travel strategies for avoiding illnesses, like the Zika virus and malaria, at the June Frontiers in Medicine lecture.

Faculty members from the School of Medicine and Health Sciences explained what they know and what they don’t know about the virus at a Feb. 12 town hall.

Recently there has been significant news coverage about the Zika Virus, which is spread to people through mosquito bites.